Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.30    0.00 (0.00%)
Bid:
1.25
Ask:
1.35
Spread: 0.10 (8.00%)
Market Cap: £20.87m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Block Listing Six Monthly Return

30 Nov 2022 07:00

RNS Number : 9723H
Genedrive PLC
30 November 2022
 

 

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Six Monthly Return

 

Name of applicant

genedrive plc

 

Name of scheme

2007 Share Option Scheme

 

Period of return:

From:

28 May 2022

To:

 30 November 2022

Balance of unallocated securities under scheme(s) from previous return:

139,226 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

139,226 shares

 

 

 

Name of contact:

Russ Shaw CFO

Telephone number of contact:

+44 (0)161 989 0245

 

For enquires:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLREKLFLLFLBFBZ
Date   Source Headline
30th Dec 20219:00 amRNSPrice Monitoring Extension
22nd Dec 202111:06 amRNSSecond Price Monitoring Extn
22nd Dec 202111:00 amRNSPrice Monitoring Extension
22nd Dec 20217:00 amRNSUK CTDA application for Genedrive® COV19-ID kit
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20211:08 pmRNSDirector/PDMR Shareholding
20th Dec 20217:00 amRNSHolding(s) in Company
14th Dec 20212:06 pmRNSSecond Price Monitoring Extn
14th Dec 20212:00 pmRNSPrice Monitoring Extension
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
9th Dec 202111:06 amRNSSecond Price Monitoring Extn
9th Dec 202111:00 amRNSPrice Monitoring Extension
9th Dec 20219:05 amRNSSecond Price Monitoring Extn
9th Dec 20219:00 amRNSPrice Monitoring Extension
8th Dec 20214:40 pmRNSSecond Price Monitoring Extn
8th Dec 20214:35 pmRNSPrice Monitoring Extension
8th Dec 20212:05 pmRNSSecond Price Monitoring Extn
8th Dec 20212:00 pmRNSPrice Monitoring Extension
8th Dec 202112:31 pmRNSCE-IVD certification for Point-of-Care kit
7th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSHolding(s) in Company
6th Dec 20214:43 pmRNSAdditional Listing of Shares
6th Dec 20212:05 pmRNSSecond Price Monitoring Extn
6th Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 20219:44 amRNSGrant of options
2nd Dec 20219:05 amRNSSecond Price Monitoring Extn
2nd Dec 20219:00 amRNSPrice Monitoring Extension
30th Nov 202111:05 amRNSSecond Price Monitoring Extn
30th Nov 202111:00 amRNSPrice Monitoring Extension
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20212:06 pmRNSSecond Price Monitoring Extn
29th Nov 20212:01 pmRNSPrice Monitoring Extension
29th Nov 202110:32 amRNSBlock listing Interim Review
29th Nov 20217:00 amRNSPOC kit submitted for CE-IVD certification
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
17th Nov 20217:00 amRNSAnnual Report and Accounts and notice of AGM
16th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSFinal Results
28th Oct 20213:40 pmRNSNotice of Results
11th Oct 20217:00 amRNSDirector's shareholding
30th Sep 20211:00 pmRNSResult of General Meeting
29th Sep 20217:00 amRNSResult of Open Offer
29th Sep 20217:00 amRNSNew Genedrive System receives CE-IVD marking
14th Sep 20217:00 amRNSPublication of Circular and Notice of GM
10th Sep 20215:03 pmRNSResult of Placing
10th Sep 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.